<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03117387</url>
  </required_header>
  <id_info>
    <org_study_id>P17.050</org_study_id>
    <nct_id>NCT03117387</nct_id>
  </id_info>
  <brief_title>Evaluation of the TOF CUFF for Perioperative Neuromuscular Transmission</brief_title>
  <official_title>Evaluation of the TOF CUFF for Perioperative Neuromuscular Transmission Monitoring During Recovery of Moderate and Deep Neuromuscular Block Compared to Acceleromyography and Electromyography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Leiden University Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acceleromyography (AMG) is the most wide spread used method to assess neuromuscular block&#xD;
      during anesthesia. However AMG is known to be inaccurate when compared to the gold standard&#xD;
      in neuromuscular transmission monitoring, electromyography (EMG). Furthermore when the&#xD;
      patients arms require to be positioned next to the body and beneath surgical drapes, AMG&#xD;
      measurements are often hindered and inaccurate. The TOF cuff is a new device which measures&#xD;
      NMB at the upper arm with a blood pressure cuff. It overcomes the previously mentioned&#xD;
      disadvantages of AMG. However, it validity compared to EMG and AMG has not yet fully been&#xD;
      investigated.&#xD;
&#xD;
      This study aims to compare the bias, limits of agreement and precision of the TOF cuff&#xD;
      relative to AMG and EMG during recovery of moderate and deep neuromuscular block in patients&#xD;
      with normal body mass index and morbidly obese patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Actual">July 1, 2020</completion_date>
  <primary_completion_date type="Actual">January 18, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Depth of neuromuscular block as measured by a train of four ratio or post tetanic count will be compared between the three devices by bland altman analysis</measure>
    <time_frame>intraoperative</time_frame>
    <description>During anesthesia, depth of neuromuscular block will be assessed at regular intervals</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">250</enrollment>
  <condition>Neuromuscular Blockade</condition>
  <arm_group>
    <arm_group_label>moderate neuromuscular block, normal body mass index</arm_group_label>
    <description>Patients with normal BMI (&lt; 30) who will receive a moderate neuromuscular block (train of four 1-3 twitches)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>deep neuromuscular block, normal body mass index</arm_group_label>
    <description>Patients with normal BMI (&lt; 30) who will receive a deep neuromuscular block (post tetanic count of 1-2 twitches)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>moderate neuromuscular block, high body mass index</arm_group_label>
    <description>Patients with high BMI (&gt; 30) who will receive a moderate neuromuscular block (train of four 1-3 twitches)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>deep neuromuscular block, high body mass index</arm_group_label>
    <description>Patients with high BMI (&gt; 30) who will receive a deep neuromuscular block (post tetanic count of 1-2 twitches)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>This study contains no interventions</description>
    <arm_group_label>deep neuromuscular block, high body mass index</arm_group_label>
    <arm_group_label>deep neuromuscular block, normal body mass index</arm_group_label>
    <arm_group_label>moderate neuromuscular block, high body mass index</arm_group_label>
    <arm_group_label>moderate neuromuscular block, normal body mass index</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        ASA I-III patients &gt;18 years of age BMI either &lt; 30 or &gt; 30 kg/m2&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA class I-III&#xD;
&#xD;
          -  &gt;18 years of age&#xD;
&#xD;
          -  Ability to give oral and written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known or suspected neuromuscular disorders impairing neuromuscular function;&#xD;
&#xD;
          -  Allergies to muscle relaxants, anesthetics or narcotics;&#xD;
&#xD;
          -  A (family) history of malignant hyperthermia;&#xD;
&#xD;
          -  Women who are or may be pregnant or are currently breast feeding;&#xD;
&#xD;
          -  Renal insufficiency, as defined by a glomerular filtration rate &lt; 30 ml/min&#xD;
&#xD;
          -  Scheduled for anesthesia without the use of muscle relaxants.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Albert Dahan, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Leiden University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medisch Centrum Haaglanden / Nederlandse Obesitas Kliniek</name>
      <address>
        <city>The Hague</city>
        <state>Zuid Holland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leiden University Medical Center</name>
      <address>
        <city>Leiden</city>
        <state>Zuid-Holland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>March 28, 2017</study_first_submitted>
  <study_first_submitted_qc>April 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2017</study_first_posted>
  <last_update_submitted>September 1, 2020</last_update_submitted>
  <last_update_submitted_qc>September 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Leiden University Medical Center</investigator_affiliation>
    <investigator_full_name>Albert Dahan</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <pending_results>
    <submitted>July 21, 2021</submitted>
    <submission_canceled>July 21, 2021</submission_canceled>
    <submitted>August 30, 2021</submitted>
    <returned>September 24, 2021</returned>
    <submitted>October 21, 2021</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

